Cargando…

Baroreflex sensitivity in facioscapulohumeral muscular dystrophy

Facioscapulohumeral muscular dystrophy (FSHD), a common form of muscular dystrophy, is caused by a genetic mutation that alters DUX4 gene expression. This mutation contributes to significant skeletal muscle loss. Although it is suggested that cardiac muscle may be spared, people with FSHD have demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Anselmo, Miguel, Coffman, Shandon, Larson, Mia, Vera, Kathryn, Lee, Emma, McConville, Mary, Kyba, Michael, Keller‐Ross, Manda L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023871/
https://www.ncbi.nlm.nih.gov/pubmed/35451178
http://dx.doi.org/10.14814/phy2.15277
_version_ 1784690435060400128
author Anselmo, Miguel
Coffman, Shandon
Larson, Mia
Vera, Kathryn
Lee, Emma
McConville, Mary
Kyba, Michael
Keller‐Ross, Manda L.
author_facet Anselmo, Miguel
Coffman, Shandon
Larson, Mia
Vera, Kathryn
Lee, Emma
McConville, Mary
Kyba, Michael
Keller‐Ross, Manda L.
author_sort Anselmo, Miguel
collection PubMed
description Facioscapulohumeral muscular dystrophy (FSHD), a common form of muscular dystrophy, is caused by a genetic mutation that alters DUX4 gene expression. This mutation contributes to significant skeletal muscle loss. Although it is suggested that cardiac muscle may be spared, people with FSHD have demonstrated autonomic dysregulation. It is unknown if baroreflex function, an important regulator of blood pressure (BP), is impaired in people with FSHD. We examined if baroreflex sensitivity (BRS) is blunted in patients with FSHD. Thirty minutes of resting BP, heart rate, and cardiovagal BRS were measured in 13 patients with FSHD (age: 50 ± 13 years, avg ± SD) and 17 sex‐ and age‐matched controls (age: 47 ± 14 years, p > 0.05). People with FSHD were less active (Activity Metabolic Index, AMI) (FSHD: 24 ± 30; controls: 222 ± 175 kcal/day; p < 0.001) but had a similar body mass index compared with controls (FSHD: 27 ± 4; controls: 27 ± 4 kg/m(2); p > 0.05). BRSup (hypertensive response), BRSdown (hypotensive response), and total BRS were similar between groups (BRSup: FSHD: 12 ± 8; controls: 12 ± 5 ms/mmHg; BRSdown: FSHD: 10 ± 4; controls: 13 ± 6 ms/mmHg; BRS: FSHD: 14 ± 9; controls: 13 ± 6 ms/mmHg; p > 0.05). Mean arterial pressure was similar between groups (FSHD: 96 ± 7; controls: 91 ± 6mmHg). Individuals with FSHD had an elevated heart rate compared with controls (FSHD: 65 ± 8; controls: 59 ± 8 BPM; p = 0.03), but when co‐varied for AMI, this relationship disappeared (p = 0.39). These findings suggest that BRS is not attenuated in people with FSHD, but an elevated heart rate may be due to low physical activity levels, a potential consequence of limited mobility.
format Online
Article
Text
id pubmed-9023871
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90238712022-04-25 Baroreflex sensitivity in facioscapulohumeral muscular dystrophy Anselmo, Miguel Coffman, Shandon Larson, Mia Vera, Kathryn Lee, Emma McConville, Mary Kyba, Michael Keller‐Ross, Manda L. Physiol Rep Original Articles Facioscapulohumeral muscular dystrophy (FSHD), a common form of muscular dystrophy, is caused by a genetic mutation that alters DUX4 gene expression. This mutation contributes to significant skeletal muscle loss. Although it is suggested that cardiac muscle may be spared, people with FSHD have demonstrated autonomic dysregulation. It is unknown if baroreflex function, an important regulator of blood pressure (BP), is impaired in people with FSHD. We examined if baroreflex sensitivity (BRS) is blunted in patients with FSHD. Thirty minutes of resting BP, heart rate, and cardiovagal BRS were measured in 13 patients with FSHD (age: 50 ± 13 years, avg ± SD) and 17 sex‐ and age‐matched controls (age: 47 ± 14 years, p > 0.05). People with FSHD were less active (Activity Metabolic Index, AMI) (FSHD: 24 ± 30; controls: 222 ± 175 kcal/day; p < 0.001) but had a similar body mass index compared with controls (FSHD: 27 ± 4; controls: 27 ± 4 kg/m(2); p > 0.05). BRSup (hypertensive response), BRSdown (hypotensive response), and total BRS were similar between groups (BRSup: FSHD: 12 ± 8; controls: 12 ± 5 ms/mmHg; BRSdown: FSHD: 10 ± 4; controls: 13 ± 6 ms/mmHg; BRS: FSHD: 14 ± 9; controls: 13 ± 6 ms/mmHg; p > 0.05). Mean arterial pressure was similar between groups (FSHD: 96 ± 7; controls: 91 ± 6mmHg). Individuals with FSHD had an elevated heart rate compared with controls (FSHD: 65 ± 8; controls: 59 ± 8 BPM; p = 0.03), but when co‐varied for AMI, this relationship disappeared (p = 0.39). These findings suggest that BRS is not attenuated in people with FSHD, but an elevated heart rate may be due to low physical activity levels, a potential consequence of limited mobility. John Wiley and Sons Inc. 2022-04-21 /pmc/articles/PMC9023871/ /pubmed/35451178 http://dx.doi.org/10.14814/phy2.15277 Text en © 2022 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Anselmo, Miguel
Coffman, Shandon
Larson, Mia
Vera, Kathryn
Lee, Emma
McConville, Mary
Kyba, Michael
Keller‐Ross, Manda L.
Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
title Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
title_full Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
title_fullStr Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
title_full_unstemmed Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
title_short Baroreflex sensitivity in facioscapulohumeral muscular dystrophy
title_sort baroreflex sensitivity in facioscapulohumeral muscular dystrophy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023871/
https://www.ncbi.nlm.nih.gov/pubmed/35451178
http://dx.doi.org/10.14814/phy2.15277
work_keys_str_mv AT anselmomiguel baroreflexsensitivityinfacioscapulohumeralmusculardystrophy
AT coffmanshandon baroreflexsensitivityinfacioscapulohumeralmusculardystrophy
AT larsonmia baroreflexsensitivityinfacioscapulohumeralmusculardystrophy
AT verakathryn baroreflexsensitivityinfacioscapulohumeralmusculardystrophy
AT leeemma baroreflexsensitivityinfacioscapulohumeralmusculardystrophy
AT mcconvillemary baroreflexsensitivityinfacioscapulohumeralmusculardystrophy
AT kybamichael baroreflexsensitivityinfacioscapulohumeralmusculardystrophy
AT kellerrossmandal baroreflexsensitivityinfacioscapulohumeralmusculardystrophy